---
title: "Molina Healthcare jumps 8% on a CMS work-rule delay; director Steven Orlando sold 702 shares at $227.33"
description: "A CMS work-rule delay bought Molina's Medicaid book time, not margin, and insiders including director Steven Orlando sold into the strength. New buyers are paying roughly 24 times a 2027 framework that is not yet guidance and must still be earned in February."
publisher: "The Inference"
section: "Health"
published: 2026-11-17T16:07:48.544Z
modified: 2026-11-17T16:07:48.544Z
canonical: https://theinference.org/article/molina-healthcare-jumps-8-on-a-cms-work-rule-delay-director-steven-orlando-sold-702-shares-at-227-33
language: en
keywords: "Molina Healthcare, Medicaid, Insider Trading, Health Insurance, CMS"
---

# Molina Healthcare jumps 8% on a CMS work-rule delay; director Steven Orlando sold 702 shares at $227.33

> A CMS work-rule delay bought Molina's Medicaid book time, not margin, and insiders including director Steven Orlando sold into the strength. New buyers are paying roughly 24 times a 2027 framework that is not yet guidance and must still be earned in February.

[Molina Healthcare](https://theinference.org/markets/companies/molina-healthcare) jumped more than 8% to $226.47 intraday on Monday, November 16, and closed up 7.5% at $225.25, ahead of [Centene](https://theinference.org/markets/companies/centene) and Elevance, after the Centers for Medicare and Medicaid Services (CMS), the federal agency that runs Medicaid, let states shield Medicaid members from work-requirement denials through June 30, 2027 [1][2].

The people who know the company best used the bounce to sell. Director Steven Orlando sold 702 shares at $227.33 that day, on [a Form 4, the SEC filing an insider must submit after a trade](https://www.sec.gov/Archives/edgar/data/1179929/000121149326000010/0001211493-26-000010-index.htm), with no 10b5-1 plan, the preset selling schedule that would make the timing automatic rather than chosen [4]. Chief legal officer Jeff Barlow sold $1.62 million of stock on November 10 at around $203, and director Dale Wolf sold $329,792 on November 13 at about $206 [5][6].

*Chart: **Two directors and the chief legal officer sold $2.1 million of Molina stock in a week** Bar chart of Molina stock sold by named insiders, in thousands of dollars: chief legal officer Jeff Barlow $1,620,000 on November 10, director Dale Wolf $329,792 on November 13, and director Steven Orlando $159,586 on November 16.*

*Shares sold by named Molina insiders, in thousands of dollars. Barlow sold $1.62 million at about $203 on November 10, Wolf sold $329,792 at about $206 on November 13, and Orlando sold 702 shares at $227.33 on the November 16 rally day, per the Form 4 filings and reports on them [4][5][6]. [4][5][6]*

## The delay changes timing, not premium

The news that moved the tape is thinner than the price move. Under [the guidance issued Friday](https://www.wusf.org/health-news-florida/2026-11-16/cms-says-states-can-delay-enforcing-medicaid-work-requirements-until-june-30), a state that opts in still assesses whether members meet work requirements but cannot deny applications or terminate coverage solely for failing them, and it must still move toward full implementation; states decide by December 11 whether to take the option [3].

That changes when members can be disenrolled, not how much premium per member Molina collects [2]. Chief financial officer Mark Keim still expects work rules and twice-yearly eligibility checks to cut Molina's Medicaid membership about 6% in 2027, and [the third-quarter medical cost ratio stands at 92.9%](https://theinference.org/article/molina-healthcare-beat-estimates-and-held-guidance-yet-its-profit-fell-53-and-the-stock-sank-about-5), where each 100 basis points is worth roughly $5 a share [2]. A six-month reprieve is timing relief, not margin repair.

*Chart: **Molina's operating margin has fallen to 1% from 4.5% in two years** Line chart of Molina Healthcare operating margin as a percent of revenue, from 4.4% in Q2 2024 down to 1.0% in Q3 2026, dipping below zero in Q4 2025.*

*Molina Healthcare operating margin, percent of revenue, by quarter, Q2 2024 to Q3 2026. Source: Molina's quarterly figures from its SEC filings [9]. [9]*

## Four dollars of the $9.50 has to show up in February

The stock now trades around 24 times Keim's "at least $9.50" 2027 framework, which he explicitly called a framework rather than guidance, and about 43 times the $5.25 2026 adjusted earnings floor [2].

The $9.50 is built as $5.25 plus $4 of named repairs: $1.50 from bringing [the new Florida CMS Kids contract](https://theinference.org/article/molina-called-its-6-billion-florida-launch-nearly-flawless-the-state-is-investigating-unpaid-claims) to breakeven, $1.00 from exiting the general-issue Medicare Advantage product, and $1.50 from administrative leverage as premium grows toward $45 billion [2]. It assumes no improvement in the Medicaid cost ratio, so every dollar of the $4 has to show up in February guidance [2]. The shares also sit above the $219.53 average analyst target on a Hold rating [2], and Baupost, [Seth Klarman](https://theinference.org/markets/people/seth-klarman)'s fund, had already trimmed its stake to about 450,000 shares from 634,000 in the third quarter, before the rally [7].

*Chart: **Four dollars of the $9.50 2027 framework is repairs Molina still has to earn** Pie chart of the $9.50 2027 framework per share: $5.25 existing 2026 adjusted EPS floor, $1.50 from bringing the Florida CMS Kids contract to breakeven, $1.00 from exiting general-issue Medicare Advantage, and $1.50 from administrative leverage.*

*How Molina builds CFO Mark Keim's "at least $9.50" 2027 framework, dollars per share, as laid out in third-quarter commentary [2]. Neither the Florida repair nor the administrative leverage is in guidance yet. [2]*

## The filings say less than the rally story does

Barron's notes the new Democratic majority in Congress could extend the delays further; that is the outlet's speculation, not a decision anyone has made [8].

What the filings state is narrower: two directors and the chief legal officer sold within a week, one at $227.33 on the rally day itself with no preset plan, and every sale price sat at or above the consensus target [4][5][6]. That does not prove anything about value, and it may be routine diversification. It does say the sellers were willing to take today's price. February guidance is where the framework gets tested: it either earns the $4 or breaks it, and a policy memo does not earn it for them [4][5][6].

## Takeaway

The reprieve runs to June 30, 2027 and changes when Molina can lose members, not what it is paid for them. Two directors and the chief legal officer sold in the week to November 16, one at $227.33 with no preset plan, and the $4 of repairs inside the $9.50 2027 framework has to appear in February guidance.

## Sources

1. [AlphaStreet, Molina Healthcare Jumps 7.5% Amid Sector-Wide Rally, 16 November 2026](https://news.alphastreet.com/molina-healthcare-jumps-7-5-amid-sector-wide-rally/)
2. [AInvest, Molina Fell 71%, Then Rose 85%. The 8% Day Rode a Delay, Not a Rate Increase, 17 November 2026](https://www.ainvest.com/news/molina-fell-71-rose-85-8-day-rode-delay-rate-increase-2611/)
3. [WUSF Public Media, CMS says states can delay enforcing Medicaid work requirements until June 30, 16 November 2026](https://www.wusf.org/health-news-florida/2026-11-16/cms-says-states-can-delay-enforcing-medicaid-work-requirements-until-june-30)
4. [SEC Form 4, Steven J. Orlando sale of Molina Healthcare shares, filed 16 November 2026](https://www.sec.gov/Archives/edgar/data/1179929/000121149326000010/0001211493-26-000010-index.htm)
5. [Investing.com, Molina Healthcare chief legal officer sells $1.62M in shares, 13 November 2026](https://www.investing.com/news/insider-trading-news/molina-healthcare-chief-legal-officer-sells-162m-in-shares-93CH-5027045)
6. [Investing.com, Molina Healthcare director Dale Wolf sells $329,792 in shares, 13 November 2026](https://www.investing.com/news/insider-trading-news/molina-healthcare-director-dale-wolf-sells-329792-in-shares-93CH-5027061)
7. [Seeking Alpha, Seth Klarman's Baupost cuts stake in Alphabet, Union Pacific; adds to CME among Q3 moves, 16 November 2026](https://seekingalpha.com/news/4672970-seth-klarmans-baupost-cuts-stake-in-alphabet-union-pacific-adds-to-cme-among-q3-moves)
8. [Barron's via Yahoo Finance, Medicaid Work Requirement Delay Pushes Molina, Centene Stocks Higher, 16 November 2026](https://finance.yahoo.com/m/9463b4e2-df38-3ec7-8d67-04299cd77d4f/medicaid-work-requirement.html)
9. [Molina Healthcare, quarterly figures from its SEC filings, retrieved 17 November 2026](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001179929)


---

Molina Healthcare jumps 8% on a CMS work-rule delay; director Steven Orlando sold 702 shares at $227.33 — The Inference. Canonical: https://theinference.org/article/molina-healthcare-jumps-8-on-a-cms-work-rule-delay-director-steven-orlando-sold-702-shares-at-227-33
